-
Remdesivir
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Remdesivir Antivirul(Ebola, Covid-19) Ko Kireara -
Ruxolitinib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Ruxolitinib Myelofibrosis Novartis Hūrae 6, 2024 -
Relugolix
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Relugolix Te mate pukupuku repeure Takeda me ASKA Hanuere 24, 2024 -
Rimegepant
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Rimegepant Mahunga o Migraine Biohaven Pepuere 22, 2031 -
Relugolix 737789-87-6
Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP Ribociclib CAS: 737789-87-6 Atineoplastic Roto-Whare -
Ribociclib 1374639-75-4
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Ribociclib 1374639-75-4 HR-pai, HER2-kino Andvance ormetastatic breast Cancers Novartis
Nga rongoāHune.27, 2028 -
Rivaroxaban
Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP Rivaroxaban Te whakakorikori Roto-Whare TDP -
Rosuvastatin konupora
Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP Rosuvastatin konupora Hypercholesterolemia I roto i te Whare/CEP 20705 √ CEP2015-240